BAX-Depleted Retinal Ganglion Cells Survive and Become Quiescent Following Optic Nerve Damage.
Ontology highlight
ABSTRACT: Removal of the Bax gene from mice completely protects the somas of retinal ganglion cells (RGCs) from apoptosis following optic nerve injury. This makes BAX a promising therapeutic target to prevent neurodegeneration. In this study, Bax+/- mice were used to test the hypothesis that lowering the quantity of BAX in RGCs would delay apoptosis following optic nerve injury. RGCs were damaged by performing optic nerve crush (ONC) and then immunostaining for phospho-cJUN, and quantitative PCR were used to monitor the status of the BAX activation mechanism in the months following injury. The apoptotic susceptibility of injured cells was directly tested by virally introducing GFP-BAX into Bax-/- RGCs after injury. The competency of quiescent RGCs to reactivate their BAX activa
SUBMITTER: Donahue RJ
PROVIDER: S-EPMC7035206 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA